RARA and cancer: Moreover, wild type RARA knock down in the T47D403 context with a RARA-targeting short hairpin RNA (shRNA) (Figure 1H, left) significantly counteracts cancer cell growth induced by high ‘supraphysiological’ RA (10-6 M) (Figure 1H, right).